Close

Vertex Pharma (VRTX): Takeaways From KOL Panel - Jefferies

September 30, 2016 8:11 AM EDT Send to a Friend
Jefferies analyst, Brian Abrahams, reiterated his Buy rating on shares of Vertex (NASDAQ: VRTX) after hosting a CF Summit with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login